江苏远航精密合金科技股份有限公司

杭州朱养心药业有限公司

一、基本情况
**企业使命**：为人类健康生活做贡献
**企业愿景**：争创历久弥新国药强企
**核心价值观**：勤勉精进、砺志自强

杭州朱养心药业有限公司成立于2001年5月，是杭州华东医药集团控股有限公司（位列中国医药工业百强榜第23名）下属的核心成员企业。公司位于杭州市钱塘区医药产业集聚地，是一家集研发、生产、销售于一体的国家高新技术企业。

公司地址为杭州市钱塘区11号大街10号，交通便捷。厂区占地7000㎡，建筑面积超11000㎡，拥有符合GMP标准的生产车间及公用配套设施，并配备通过CNAS实验室认可的检测场所。

科技创新是企业的核心竞争力。朱养心药业在新形势下重新定位产品研发与科技创新战略，聚焦“风湿免疫、抗肿瘤”等核心领域，同时布局“皮肤外用制剂”等特色差异化产品。目前在研项目十余项，已获发明专利32项、外观专利3项。公司设有体系完整的药物研究所，包括制剂研究技术平台、质量研究技术平台、外用药开发和产业化平台等，并不断完善研发项目注册及管理体系。研发技术人员为核心支柱力量，多数具备硕士及以上学历且经验丰富。

在国家药品集采背景下，朱养心药业积极开拓基层市场和自费市场。在2022年实现7亿销售目标的基础上，计划于2027年组建超千人营销团队，实现销售规模达20亿元。

公司秉持“一手抓新产品开发，一手抓市场营销”的理念，致力于成为以科研开发和技术创新为引领、覆盖全国市场的新型医药工业企业。

笔克展览服务（深圳）有限公司

Penko is an internationally renowned expert in comprehensive brand activation, excelling at engaging audiences, creating experiences, and energizing brands.

As a source of creative inspiration and innovation, Penko crafts impactful brand experiences through comprehensive brand activation strategies, blending insightful strategies with meticulous execution to breathe new life into client brands.

Penko specializes in solution-driven experience design, building upon a legacy of excellence spanning five decades, now seamlessly integrating cutting-edge technology, compelling content, and various production services to bring wonder to every corner of the world, creating immersive experiences for audiences.

Understanding client business considerations, we proactively meet their needs to ensure optimal return on investment. The "Penko+" approach combines integrated marketing and data-driven solutions, merging creative insights from innovative technologies with physical spaces and real-time experiences to generate compelling, lasting experiences that drive desired outcomes – igniting audience anticipation, fueling enthusiasm, and quantifying brand loyalty.

Our global team of over 2,000 specialists across nearly 40 cities worldwide strengthens our international presence. Comprising teams with diverse cultural backgrounds and industry expertise, as well as state-of-the-art facilities totaling almost 100,000 square meters across regions, Penko can excel in activations across platforms including exhibitions, events, retail, themed environments, visual identity, sports marketing, temporary venue facilities, venue management & consultancy, content creation, sponsorship initiatives, offline interactive marketing, online interactive marketing, and digital & tech solutions.

Penko Group was awarded the Gold Prize in the "Event Marketing Agency" category of the "Marketing" magazine's 2019 Annual Marketing Agencies Awards. In 2017, the company was selected as the "Best Project Planner" in the Asia-Pacific region in the "CEI Readers' Choice" awards; since 2012, Penko has consistently ranked among the top 50 project planning companies in North America in "Special Events" magazine's "Top 50 Project Planning Companies." In 2018, Penko Group received the "ESG Report Award – Small Market Capital" at the Hong Kong Environmental, Social, and Governance Reporting Awards.

Penko Far East Limited was listed on the Hong Kong Stock Exchange (stock code: 752) in 1992, and its affiliate, Pico (Thailand) Public Company Limited, was listed on the Thailand MAI (stock code: PICO) in 2004. In the fiscal year 2018, Penko Far East Limited reported revenue of $590 million, with a market capitalization of $417 million as of October 31, 2018.

Benefits include:

- Comprehensive insurance (Five insurances and one公积金)
- Corporate insurance
- Team-building activities, annual events, birthday parties, fitness programs
- Paid vacation of 7-21 days
- 5-day workweek
- Professional training: in-house training, external training; once a year, there is an opportunity to apply for training qualifications in Singapore headquarters.

For interested candidates, please submit your resume and portfolio via email to our company. We will arrange interviews if suitable.
(Indicate the position you are applying for)

Human Resources Department Email: sz.repoffice@pico.com

四川双铁科技有限公司

**企业概览**

四川双铁科技有限公司成立于2005年，是一家专注于轨道交通领域的实体企业。作为四川省高新技术企业、科技型培育企业和“专精特新”中小企业，我们以创新为核心，致力于为轨道交通行业提供高质量的产品与服务。

**专利与基地**

至今，双铁科技已累计获得发明专利和实用新型专利超过50项，拥有近100亩的研发和制造基地，为持续的技术创新和产品升级奠定了坚实的基础。

**行业贡献与荣誉**

作为“中国城市轨道交通协会”的会员单位和“成都市轨道交通重点配套企业”，我们积极参与行业标准制定，包括参与原铁道部《铁路工程建设声屏障通用参考图》的编制工作（编号：8321、8327、8328）。此外，在四川省“铁路拼装式声屏障立柱”创新创业菁英活动中，我们荣获了菁英赛大奖，展现了公司在技术创新方面的卓越实力。

**产学研合作与发展战略**

我们与西南交通大学、中铁二院、川藏铁路创新中心等高校和科研机构建立了紧密的合作关系，通过构建“产、学、研”一体化发展模式，不断推动研发创新，提升产品质量和技术水平，增强企业核心竞争力和行业影响力。

易明医药

易明医药创建于2003年，是一家集新药研发、产业投资、生产和销售于一体的创新型医药企业。其控股母公司坐落于西藏自治区拉萨市国家级经济技术开发区，作为首批入驻该区域的企业，展现出强劲的发展潜力。

近年来，易明医药实现了快速扩张，于2016年在深交所中小板成功上市，股票代码为002826。公司始终坚持产品为核心竞争力的战略思想，构建了独具特色且全面的医药健康产业平台。这一平台基于中药材生产质量管理规范（GAP）、药品生产质量管理规范（GMP）及药品经营质量管理规范（GSP）三大标准化体系，同时围绕以自主创新为核心的目标，形成了药物开发、技术植入、药品生产和药品营销四大模块相互支撑、协同发展的稳定增长模式。

易明医药旗下拥有位于拉萨、北京、成都等地的多家医药研发、生产和销售公司，这些企业均在当地医药行业处于领先地位。其中，北京易明康元医药科技有限公司和四川维奥制药有限公司均被认定为国家级高新技术企业和成都市高新技术企业。公司根据不同地域和公司的独特性，采取灵活策略，专注于药物开发、技术引进、药品生产、销售网络建设、市场渠道扩展、医药行业投资以及依托本地资源优势发展健康事业项目等关键领域，实现全方位、快速推进业务发展。

秉持“致力于医药产业，服务人民健康”的使命，易明医药始终坚守“平易近人，务实创新；诚信经营，追求卓越”的企业精神，不断创新与开拓，正稳步迈向大型综合性医药企业的行列。

鉴于公司持续发展需要，现诚邀各界精英加盟，共创辉煌未来。